INS and cancer: It also causes several changes in energy metabolism and nutritional status, inducing anorexia [34], corticotropin-releasing factor and somatostatin secretion [35], with a consequent muscle mass reduction, which is typical of advanced cancer patients [36], and insulin synthesis, leading to hyperinsulinemia and insulin resistance [37].